Citation Impact
Citing Papers
p53: puzzle and paradigm.
1996 Standout
Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Production during Simian Immunodeficiency Virus Infection with a Nonpathogenic Outcome
2008 StandoutNobel
Acute Infection with Epstein-Barr Virus Targets and Overwhelms the Peripheral Memory B-Cell Compartment with Resting, Latently Infected Cells
2004
Infective Endocarditis
2005 Standout
Natural History of Epstein‐Barr Virus Infection in a Prospective Pediatric Cohort Born to Human Immunodeficiency Virus‐Infected Mothers
1998
Nasopharyngeal carcinoma
2005 Standout
Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity.
1997 Standout
Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture
1996 Standout
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
1999 Standout
Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications
2000
Congenital syphilis: A continuing but neglected problem
2007
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
1992 StandoutNobel
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Clinical Trial of Safety and Efficacy of IHN-A21 for the Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature Infants
2007
Soft-Tissue Sarcomas in Adults
2005 Standout
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
2002
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases
2006 Standout
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology
2005
Global cancer statistics
2011 Standout
Unique Features of Infective Endocarditis in Childhood
2002
Fetal immunization of baboons induces a fetal-specific antibody response
1999
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Biological aspects of Epstein–Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies
2002
Epstein–Barr virus: 40 years on
2004 Standout
Molecular Basis of Latency in Pathogenic Human Viruses
1991 Science
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation
1994
Gammaherpesviruses and “Hit-and-Run” Oncogenesis
2000
Multicenter Study to Assess Safety and Efficacy of INH-A21, a Donor-Selected Human Staphylococcal Immunoglobulin, for Prevention of Nosocomial Infections in Very Low Birth Weight Infants
2005
Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.
1997
p73 is a human p53-related protein that can induce apoptosis
1997 StandoutNatureNobel
The interleukin-10 homolog encoded by Eepstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses
1992
Detection of Epstein-Barr Virus in Invasive Breast Cancers
1999
Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators.
1989
Maternal and child health in Brazil: progress and challenges
2011 Standout
Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas
1995 Standout
Idiopathic pulmonary fibrosis
2011 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Molecular Diagnosis of Epstein-Barr Virus-Related Diseases
2001
An Updated Review on Cryptosporidium and Giardia
2006
SEC23-SEC31 the Interface Plays Critical Role for Export of Procollagen from the Endoplasmic Reticulum
2012 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Identification of microRNAs of the herpesvirus family
2005 StandoutNobel
Epstein–Barr Virus Infection
2000 Standout
Virally targeted therapies for EBV-associated malignancies
2003
A Rearranged Form of Epstein–Barr Virus DNA Is Associated with Idiopathic Pulmonary Fibrosis
2002
A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter
1995 StandoutNobel
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
1996 Standout
Epstein-Barr Virus Immediate-Early Protein BZLF1 Is SUMO-1 Modified and Disrupts Promyelocytic Leukemia Bodies
2001
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Separate cis-regulatory elements confer expression of phosphoenolpyruvate carboxykinase (GTP) gene in different cell lines.
1989
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements.
1990 StandoutNobel
DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.
1994
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
1993 StandoutNobel
AIDS-Related Malignancies
2003
Synthesis and Electrochemistry of 2-Ethenyl and 2-Ethanyl Derivatives of 5-Nitroimidazole and Antimicrobial Activity against Giardia lamblia
2009 StandoutNobel
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation
1993
RANTES Binding and Down-Regulation by a Novel Human Herpesvirus-6 β Chemokine Receptor
2000
NITRIC OXIDE AND MACROPHAGE FUNCTION
1997 Standout
Frontiers In Antimicrobial Resistance: A Tribute To Stuart B. Levy
2005
Infection of human endothelial cells with Epstein-Barr virus.
1995
Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6
1993
An analysis of vertebrate mRNA sequences: intimations of translational control.
1991 Standout
Classic Kaposi sarcoma
2000
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas
2004
Human Erythropoietin Gene Expression in Transgenic Mice: Multiple Transcription Initiation Sites and cis-Acting Regulatory Elements
1990 StandoutNobel
Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection
2004 StandoutNobel
Negative regulation of the BZLF1 promoter of Epstein-Barr virus
1991
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.
1994
Protein Modification by SUMO
2004 Standout
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.
1996 StandoutNobel
Herpesvirus papio encodes a functional homologue of the Epstein–Barr virus apoptosis suppressor, BHRF1
2000
Cranio‐lenticulo‐sutural dysplasia associated with defects in collagen secretion
2010
Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia
1994
Origins and Evolution of Antibiotic Resistance
2010 Standout
Global cancer statistics, 2012
2015 Standout
Bacillus cereus and related species
1993 Standout
Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain
1992
SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
2006
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Cytokine production in the immune response to murine gammaherpesvirus 68
1996 StandoutNobel
Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1.
1992 StandoutNobel
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and β-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
2003 StandoutNobel
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of Hal B. Jenson being referenced
Benign and Malignant Smooth Muscle Tumors Containing Epstein-Barr Virus in Children with AIDS
1997
Natural History of Primary Epstein‐Barr Virus Infection in Children of Mothers Infected with Human Immunodeficiency Virus Type 1
1999
PUNCTURE WOUND OSTEOCHONDRITS OF THE FOOT CAUSED BY PSEUDOMONAS MALTOPHI
1990
Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency
1988
Epidemiology of Herpesvirus Papio Infection in a Large Captive Baboon Colony: Similarities to Epstein‐Barr Virus Infection in Humans
2000
Human Herpesvirus 6 Infection of the Female Genital Tract
1994
Prevalence of Cryptosporidium parvum infection in children along the Texas-Mexico border and associated risk factors.
2000
Treatment of multiple brain abscesses caused by Bacillus cereus
1989
Association of Epstein–Barr Virus with Leiomyosarcomas in Young People with AIDS
1995
An efficient method for routine epstein-barr virus immortalization of human B lymphocytes
1995
Antibodies to Kaposi's Sarcoma—Associated Herpesvirus (Human Herpesvirus 8) in Patients with Multiple Myeloma
1998
Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.
1987
Pediatric Infectious Diseases: Principles and Practice
1995
Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.
1988
Epstein-Barr Virus
2011
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency
1987
The baboon as a nonhuman primate model for assessing the effects of maternal immunization with Haemophilus influenzae type b polysaccharide vaccines
1997
Sequences of the Epstein-Barr Virus (EBV) large internal repeat form the center of a 16-kilobase-pair palindrome of EBV (P3HR-1) heterogeneous DNA
1987
Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma
1999
Meta-analyses of the Effectiveness of Intravenous Immune Globulin for Prevention and Treatment of Neonatal Sepsis
1997
Congenital syphilis
1999